JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: GW441756 (GW-441756) is a novel, potent and selective inhibitor of TrkA (Tropomyosin-related kinase A) with potential anticancer activity. It inhibits TrkA with an IC50 of 2 nM, and shows no/little activity against c-Raf1 and CDK2. The activity of TrkA kinase can affect its downstream signaling and involves in many biological processes including proliferation, differentiation and apoptosis. GW 441756 exhibits excellent anti-proliferative activity in human muscle sarcoma cancer cell line HTB114, and treatment of GW441756 dose-dependently suppressed the proliferation and induced apoptosis. Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
References: Bioorg Med Chem Lett. 2004 Feb 23; 14(4):953-7; Exp Mol Med. 2008 Jun 30; 40(3): 276–285; Mol Cells. 2008 Jul 31; 26(1):12-7.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!